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Introduction
Every member in the care team has the same fiduciary
obligation that is to protect and promote patients’
health-related interests and implement patients’ 
preferences in pursuit of this goal. However, the con-
flicting interests of end-of-life (EOL) care result in stress
for intensivists in clinical practice. The urgent need 
for treatment and complexity of the diseases being
cared for in an intensive care unit (ICU) make the 
situation even more complicated. The purpose of this
article is to clarify the situation the intensive care
team meets on a daily basis, and to equip them to
deal with the ethical issues associated with these
dilemmas.
Good EOL Care—Where We Are in Taiwan
There is a growing number of issues concerning the
quality of EOL in modern medicine1–3. Physicians in
Taiwan are engaged in applying palliative care con-
cepts to care for the patients in the terminal stages of
their cancer in hospice units4. They are well practiced
in the concerns to alleviate the suffering in dying
patients and the grief of family caregivers4.
ICUs are environments where patients have illnesses
of high morbidity and mortality5. There is a high fre-
quency of intensivists and oncologists dealing with the
EOL care for patients in ICU. Attaining good EOL care is
as important as prescribing life-sustaining management
in ICU6,7. Several activities have been held to promote
palliative care principles and service in intensive care4.
Patient Characteristics in the ICU—
What Situations Do We Encounter
The ICU is a specialized medical environment where
critically ill patients are cared for. Patients in ICU have
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their own unique characteristics. Their mortality rates
are high, varying from 10% to 20% in different ICUs5.
Half of them will die within 3 days after admission to
the ICU8. One-third of the patients spend more than
10 days in the ICU during their final hospitalization8.
Most patients at the onset of critical illness are ill-
prepared to accept death. Their deaths almost always
occur earlier than expected.
Avoidance of futile care is an essential task in ICU,
since the ward is supposed to resuscitate dying patients9.
These conflicts come from not only the dilemma of
human dignity between the right of life and death,
but also the dilemma of differing attitudes toward EOL
care between the medical staff and family members10.
The Major Barrier of Practicing Good EOL
Care in the ICU
Patients in ICU need care that focuses not only on life
sustainment but also on comfort9. However, every
patient’s background is different. Personal attitudes
towards life are so heterogeneous that we can hardly
expect to know their wishes for EOL care without com-
munication11. The factors influencing EOL care decisions
include age, diagnosis of the disease, severity of the
disease(s), length of hospital stay, cost of medical care,
and different beliefs based on geography and reli-
gion12–14. In Taiwan, although there is no available 
data regarding diverse decisions of EOL care between
patients and their clinicians in the ICU, this fact has
been shown in cancer groups10.
Holistic care includes not only curative care but
also palliative care. Patients in the ICU do change their
wishes with regards to their health conditions6. As the
patients’ conditions in ICU changes minute by minute9,
and because futile therapy should be avoided15, 
frequent communication to clarify patients’ demand
for the goal of management at different points in 
the disease process is essential in attaining good 
EOL care16.
Difficulty assessing the appropriate use of advanced
technology in an incapable patient is another com-
mon problem in ICU. Several features in the ICU such
as an ill patient incapable of making decisions autono-
mously, a new care team17, difficulty in organizing meet-
ings11, overbearing family members11 and discordant
views on appropriate care among care givers10,11,18,19–22
have made this problem more complicated.
What Concepts Should We Be Aware of to
Overcome the Dilemma of Attaining a 
Good EOL Care in the ICU?
In view of the patients’ backgrounds and the influenc-
ing factors for good EOL care in ICU, only a qualified
intensivist can guarantee individualized EOL care 
during the different stages of the disease for each
patient11. The concepts that are essential to attain a
patient-centered good EOL care in ICU are outlined
below.
A good death or good EOL care
There are five components to good EOL care that
meets a dying patient’s needs: comfort, absence of
pain, dignity and respect, closeness to significant fam-
ily members and other caring persons, and peace.
These are most frequently considered part of a good 
death23.
Autonomy
Rather than paternalism, a patient’s autonomy is a
sovereignty of medical ethics during medical decision
making. Three elements in “real” autonomy should be
considered: the patients’ competence, understanding,
and willingness24.
There are four questions that a clinician needs to
ask in order to assess whether patients have the capac-
ity to make decisions autonomously: Do they under-
stand the nature of the procedure? Do they realize 
the purpose and the effects of the proposed therapy?
Do they have the ability to comprehend and retain 
relevant information? Can they weigh up the benefits
and disadvantages of various interventions?
However, it is difficult for the patient to imagine
completely what will occur as a result of their deci-
sions. A gap exists between a patient’s understanding
and reality. This is not only because patients are not
familiar with the language of medicine, but also
because most of them cannot really remember what
has been mentioned by the clinicians. In addition, the
inherently uncertain nature of medicine sometimes
also leads to misunderstandings between caregivers
and the patients.
Consent is also a primary element of patient’s
autonomy. Physicians should give more weight to the
patients' interests rather than their own. Clinicians
should avoid manipulating the medical information
or coercing their patients during communication.
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Medical futility
The strict definition of futile care is still being debated
by health care professionals, bioethicists, investigators,
and other experts. The definition of a futile treatment
should not only be based on a success rate of less than
1 in 100 treatments25, but also focused on other fac-
tors, such as quality of life, the emotional and finan-
cial costs of treatment, the likelihood of treatment
success and the expected effect on longevity26. The per-
ceptions of patients regarding medical futility should be
explored and should be considered in the decision26.
Any reasonable doubt or uncertainty about the irre-
versibility of a patient’s medical condition is appropriate
to initiate intensive care. Frequent queries, reappraisals
of the effect of management, and realistic, honest med-
ical advice in combination with patient and family
input on EOL choices are the best way to determine if
the treatment is futile6,15.
Palliative care
The distress of patients in the ICU is varied27. Inter-
ventions in the ICU can increase patient discomfort27.
Patients may have a reduced quality of life28. Palliative
care in the ICU is an approach that assists the patients
and their families to face the discomfort associated
with life-threatening illness1,29. Physical, psychologic
and spiritual distress can be prevented and relieved 
by early identification and excellent treatment. Given
that dying is a normal process of life, physicians who
care for patients should neither hasten nor postpone
their death. An explicit patient-centered decision mak-
ing process for EOL care, including discomfort assess-
ment and control, decisions about life-sustaining
therapy, minimizing the symptoms during withdraw
therapy and maximizing support for the bereavement
of the family, are the body of palliative care in the
ICU13,19,30,31.
Ethical difference between withholding and
withdrawing treatment
Actions taken in EOL care can be grouped into distinct
categories including cardiopulmonary resuscitation13,
withholding or withdrawing treatment12,17,32,33, and
active euthanasia or active shortening of the dying
process34. These therapies are also the main EOL deci-
sions during an ICU stay6. These actions have been
applied more frequently in recent years17. Withholding
treatment is defined as “failing to initiate therapy” and
withdrawing treatment as “stopping therapy”. In theory,
except the difference in the timing of the action, a jus-
tification for not commencing a treatment is sufficient
for ceasing it.
In practice, cultural variances in different countries
have affected the way these two management practices
are performed. In Taiwan, clinicians can apply these
two therapies based on the “Hospice Palliative Medical
Act” of May 2000, which was revised in November
200235. The main idea behind this law is that “the
patient who will unavoidably die in the visible future
because of incurable diseases, which has been con-
firmed by two doctors, has the right to refuse accep-
ting life-sustaining management”. Clinicians in Taiwan 
can perform withholding treatment under either the
patients’ or their surrogates’ wishes, but they can only
manage withdrawal therapy under the patient’s auto-
nomy with written documentation34.
Ethical differences among withdrawing treatment,
physician-assisted dying and killing
Although withdrawal of treatment may or may not
hasten death36, it differs from active euthanasia in
that sole intent of hastening death obstructs provision
of treatment. Physician-assisted dying and killing is
unacceptable in most countries in the world, includ-
ing Taiwan. On the other hand, the concept that
patient autonomy can be an overriding force in deci-
sion making at the EOL has been approved in some
areas, including Oregon and the Netherlands.
Double effect
Clinicians prescribe management because these inter-
ventions are good for the patient, but inherent unin-
tended “bad” effects may exist at the same time. 
A common example is cardiorespiratory depression in
opioid agents for terminal sedation and analgesia6,
There is no clear distinction between the dose of opiates
and benzodiazepines for withdrawal therapy and for
active life-shortening, further proving this phenome-
non12,34. This phenomenon has been called the “double
effect”. There is a consensus, “the doctrine of double
effect in practice”, having been set to protect patients’
benefit and to confirm the intensivists’ morality24. 
We are using morphine as an example to show its 
utility:
1. The act itself must be morally permissible.
• Morphine for pain is morally permissible.
2. The negative effect, while possible to predict, must
be unintended.
• Morphine for pain rather than for respiration
depression.
3. The negative effect must not be disproportionate
to the good effect.
• Morphine for pain outweighs loss of life in a
dying patient.
4. The negative effect is not the means by which the
good effect is achieved.
• Pain is relieved by the administration of mor-
phine and not by the death of the patient.
To increase the transparency at EOL care, proper docu-
mentation, including record keeping on timing and
doses of drug and the physician’s intention at each step,
is recommend34.
Justice
It is difficult for a human to clarify one therapy as a
futile management or a life-sustaining high technol-
ogy. Since resources are undeniably limited, we may
deprive one patient the chance of surviving, while 
we rescue another one in every way. We suggest the
formation of a national institute to oversee just the
medical resource allocation24.
Uncertainty
Why do we try to avoid discussing death in conversa-
tion? Can we predict when or how we will die? The
sense of losing control makes us feel the anxiety and
fear, as we face the issues of death6. These emotions
are common and normal. Medical uncertainties in
dealing with EOL care, such as the prognosis of dis-
eases, illness progression, death, modest dosing of
pain medication and the death process, also make
caregivers uncomfortable. However, recognizing the
situation that we are involved in is the best way to
overcome this challenge.
Conclusion
Autonomy, beneficence, non-malfeasance and justice
continue to be the basis of medical bioethics. Recogni-
tion of the double effect of management as relieving
patients’ suffering, performing withholding and with-
drawing life-sustaining therapy according to the “Hos-
pice Palliative Medical Act” and overcoming the stress
from uncertainty of the clinical medicine are espe-
cially useful for the intensivists handling the palliative
and intensive care morally in the ICU. Furthermore,
accounting for cultural influence factors, such as the
legal constraints, religious beliefs and sociocultural
circumstances, and physician’s experience with similar
cases will resolve the conflicting interests in EOL care
in a correct way, and achieve patient-centered medical
care based on sound ethical reflection and judgment.
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